23andmeaduhelmaheadaialarmingalnylamalzheimeramgenanotherapprovalascoastrazenecabadbidenbigbiobiogenbiotechbirdblockbusterblockbustersboldboombrainbreakthroughcancercarecasecdccellceoceoschinachineseconferencecontroversialcontroversycoronaviruscovidcrisiscrisprcurecutsdatadaydealdealmakingdebatedeepdilemmadiseasednadramadrugdrugseffectselectionendeveryexperimentfakefalloutfaucifdafirstfluftcfundingfuturegenegeneticgenomegeorgegetgileadglpgoldgottliebhealthhearthistoryholmeshothypeilluminaindustryinsideinsiderinsulinintriguejpmjrkidslatestlayoffslegacylegallifelillylivelonglooklossmarketmeansmedicalmedicinemerckmergermessymilestonemodernamorganmrnanewsnextnihnobelnomineenovartisnovoobesityomicronopioidoutbreakpandemicpartypatientspfizerpharmapivotplanplanspleaplightpluspotentialprasadpreviewpricespricingpromisepsychedelicsquestraceredrememberingreportresearchresponsereturnreviewrfkriserisksrushsagasareptasciencescottsetbackshkrelishortagessicklestakesstartupstartupsstatstocksstorystudysuccesssummitsurprisetakestechtestingtheranostherapiestherapytradingtreatmenttrialtrialstrumpturmoilturnaroundtwitterupheavalvaccinevaccinesvcvcsvertexweekwegovyweightworldwrongyear